SEC Form SC 13G filed by CeriBell Inc.

11/7/24 9:24:55 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $CBLL alert in real time by email

SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 CERIBELL INC COMMON STOCK Cusip #15678C102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #15678C102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 4,527,866 Item 6: 0 Item 7: 4,541,566 Item 8: 0 Item 9: 4,541,566 Item 11: 13.350% Item 12: HC Cusip #15678C102 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 4,541,566 Item 8: 0 Item 9: 4,541,566 Item 11: 13.350% Item 12: IN Item 1(a). Name of Issuer: CERIBELL INC Item 1(b). Address of Issuer's Principal Executive Offices: 360 N. PASTORIA AVENUE SUNNYVALE, CA 94085 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 15678C102 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 4,541,566 (b) Percent of Class: 13.350% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 4,541,566 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CERIBELL INC. No one other person's interest in the COMMON STOCK of CERIBELL INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 6, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 6, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of CERIBELL INC at October 31, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $CBLL alert in real time by email

Date

Price Target

Rating

Analyst

4/4/2025

$32.00

Buy

Ladenburg Thalmann

11/5/2024

$32.00

Buy

BofA Securities

11/5/2024

$30.00

Buy

Canaccord Genuity

11/5/2024

$32.00

Overweight

JP Morgan

11/5/2024

$31.00

Buy

TD Cowen

11/5/2024

Outperform

William Blair

SEC Form SC 13G filed by CeriBell Inc.

11/7/24 9:24:55 AM ET

$CBLL

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $CBLL alert in real time by email

Date

Price Target

Rating

Analyst

4/4/2025

$32.00

Buy

Ladenburg Thalmann

11/5/2024

$32.00

Buy

BofA Securities

11/5/2024

$30.00

Buy

Canaccord Genuity

11/5/2024

$32.00

Overweight

JP Morgan

11/5/2024

$31.00

Buy

TD Cowen

11/5/2024

Outperform

William Blair

SEC Form SC 13G filed by CeriBell Inc.

Chat with this insight

Recent Analyst Ratings for $CBLL

SEC Form SC 13G filed by CeriBell Inc.

Chat with this insight

Recent Analyst Ratings for $CBLL

$CBLL Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Ladenburg Thalmann initiated coverage on CeriBell with a new price target

BofA Securities initiated coverage on CeriBell with a new price target

Canaccord Genuity initiated coverage on CeriBell with a new price target

$CBLL Press Releases

Fastest customizable press release news feed in the world

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

Ceribell Reports First Quarter 2025 Financial Results

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

$CBLL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$CBLL SEC Filings

$CBLL Large Ownership Changes

This live feed shows all institutional transactions in real time.

$CBLL Leadership Updates

Live Leadership Updates

$CBLL Financials

Live finance-specific insights

$CBLL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner Tpg Gp A, Llc converted options into 3,587,154 shares and bought $6,464,556 worth of shares (380,268 units at $17.00) (SEC Form 4)

Director Tammenoms Bakker Juliet was granted 6,618 shares, converted options into 2,140,600 shares and bought $4,032,978 worth of shares (237,234 units at $17.00) (SEC Form 4)

CeriBell Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form DEFA14A filed by CeriBell Inc.

SEC Form 144 filed by CeriBell Inc.

SEC Form SC 13G filed by CeriBell Inc.

SEC Form SC 13D filed by CeriBell Inc.

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

Ceribell Reports First Quarter 2025 Financial Results

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

President and CEO Chao Xingjuan exercised 25,000 shares at a strike of $2.24 and sold $425,000 worth of shares (25,000 units at $17.00) (SEC Form 4)

President and CEO Chao Xingjuan exercised 73,871 shares at a strike of $1.02 and sold $424,000 worth of shares (25,000 units at $16.96), increasing direct ownership by 7% to 776,022 units (SEC Form 4)

President and CEO Chao Xingjuan sold $240,657 worth of shares (15,928 units at $15.11), decreasing direct ownership by 2% to 727,151 units (SEC Form 4)

Recent Analyst Ratings for
$CBLL

Recent Analyst Ratings for
$CBLL

$CBLL
Analyst Ratings

$CBLL
Press Releases

$CBLL
Insider Purchases

$CBLL
SEC Filings

$CBLL
Large Ownership Changes

$CBLL
Leadership Updates

$CBLL
Financials

$CBLL
Insider Trading